University of Lorraine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents

    Diabetes, Obesity and Metabolism, Vol. 19, Núm. 12, pp. 1798-1804